Mentice, the world leading provider of endovascular performance
solutions, today announced the appointment of Dr. David J. Ballard as
Chief Clinical Officer and Executive Vice President of the Mentice
Group. Dr. Ballard was previously appointed an independent member of the
Mentice board of directors in October 2018.
“I am excited to join the Mentice executive team, in addition to
continuing to engage my existing role on the Mentice board,” says Dr.
Ballard. “I have spent the last couple of months educating myself on the
opportunities to leverage Mentice solutions to reduce harm to patients,
and to make health care more affordable. We have excellent opportunities
to make significant contributions towards achieving both these
objectives in partnership with healthcare systems across the world.”
Dr. Ballard (M.D., M.S.P.H., Ph.D., F.A.C.P.) is a health care
executive with proven expertise in improving healthcare value and
organizational financial performance, while providing international
thought leadership. Dr. Ballard was recognized by Becker’s
Hospital Review as one of the top 50 experts leading the field of
patient safety in 2015, 2016, 2017 and 2018.
A past president of the International Society for Quality in Health
Care, Dr. Ballard in 2008 received the Distinguished Alumnus Award from
the University of North Carolina School of Medicine. Widely recognized
as a scholar in health care quality and value, his two books on health
care quality leadership have received Shingo Awards for their
contributions to operational excellence.
Dr. Ballard served the past 19 years as Chief Quality Officer of Baylor
Scott & White Health, the largest health care system in Texas. He has
also served in leadership roles at Emory University (1994-1999),
University of Virginia (1991-1994) and the Mayo Clinic. He holds degrees
in economics, epidemiology and medicine from the University of North
Carolina where he was a John Motley Morehead Scholar. Dr. Ballard
trained in internal medicine at the Mayo Clinic and served from 1986-91
on the Mayo staff as Consultant, Associate Professor and Head of the
Section of Health Services Evaluation, where he now serves as Healthcare
Policy Section Editor for the Mayo Clinic Proceedings. Dr. Ballard is a
member of the Chancellor’s Global Leadership Council at the University
of North Carolina where he is also Adjunct Professor of Health Policy
and Management in the UNC Gillings School of Global Public Health.
“I’m thrilled to welcome Dr. Ballard to our team,” says Goran Malmberg,
Group CEO of Mentice. “Dr. Ballard will help drive our engagement with
health systems, and I cannot think of a better person for this role.
Mentice has a unique technology and a market-leading position with
premier medical device corporations and academic institutes worldwide.
We believe the largest opportunity for our solutions is within the field
of continuous practice and with leading health systems—areas where we
are just beginning.”
Mentice is the world leader in virtual reality?based
interventional medical simulation solutions. Our solutions help
healthcare professionals with skills acquisition, continuous development
and pre-procedural planning—leading to improved productivity and
outcomes. Mentice solutions are scientifically validated and have been
specifically developed for healthcare providers and the medical
industry. Neurovascular, cardiovascular and peripheral interventions are
just some of the areas covered by our systems. For more information
about Mentice, visit www.mentice.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190109005063/en/